Senior insider sale
PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$27.20M
291.92K shares
What this filing means
TORLEY HELEN plans to sell 291.92K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $27.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001968582-26-000846
DirectorOfficer· PRESIDENT AND CEO
Since Mar 2026
291.92K
Shares to sell
$27.20M
Approx. market value
240K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/17/2026
240KTotal acquired240K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Stock Option Exercise Cash | 240K | — |
| Total | 240K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.92K
Market value
$153.4K
7/8/2026
—Completed
Units to sell
10K
Market value
$690.7K
6/3/2026
—Completed
Units to sell
20K
Market value
$1.33M
6/2/2026
—Completed
Units to sell
20K
Market value
$1.35M
6/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
240K
Market value
$23.68M
8/17/2026
Total
Units
291.92K
Value
$27.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/8/2026 | 1.92K | $153.4K | — | Completed |
6/3/2026 | 10K | $690.7K | — | Completed |
6/2/2026 | 20K | $1.33M | — | Completed |
6/1/2026 | 20K | $1.35M | — | Completed |
| Planned — Approximate Date | ||||
8/17/2026 | 240K | $23.68M | NASDAQ | Planned |
| Total | 291.92K | $27.20M | ||